Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amphetamine-Related Disorders | 2 | 2020 | 63 | 1.230 |
Why?
|
| Methamphetamine | 2 | 2020 | 155 | 1.110 |
Why?
|
| Substance-Related Disorders | 3 | 2020 | 685 | 0.880 |
Why?
|
| Mexico | 10 | 2020 | 223 | 0.870 |
Why?
|
| Unsafe Sex | 2 | 2020 | 161 | 0.730 |
Why?
|
| Referral and Consultation | 1 | 2018 | 110 | 0.650 |
Why?
|
| Health Personnel | 1 | 2018 | 200 | 0.580 |
Why?
|
| Risk-Taking | 1 | 2020 | 435 | 0.570 |
Why?
|
| Substance Abuse, Intravenous | 4 | 2010 | 123 | 0.570 |
Why?
|
| Women | 1 | 2015 | 26 | 0.550 |
Why?
|
| Homosexuality, Male | 2 | 2020 | 438 | 0.550 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 125 | 0.550 |
Why?
|
| Quality of Health Care | 1 | 2015 | 136 | 0.500 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 531 | 0.500 |
Why?
|
| Vulnerable Populations | 1 | 2015 | 132 | 0.480 |
Why?
|
| Central Nervous System Stimulants | 1 | 2015 | 165 | 0.480 |
Why?
|
| Texas | 3 | 2020 | 299 | 0.470 |
Why?
|
| HIV Infections | 5 | 2020 | 2207 | 0.460 |
Why?
|
| Needle Sharing | 1 | 2010 | 10 | 0.380 |
Why?
|
| Syphilis | 1 | 2010 | 27 | 0.370 |
Why?
|
| Adult | 11 | 2020 | 11034 | 0.330 |
Why?
|
| Decision Making | 1 | 2009 | 189 | 0.300 |
Why?
|
| Information Dissemination | 1 | 2007 | 58 | 0.300 |
Why?
|
| Female | 12 | 2020 | 19873 | 0.300 |
Why?
|
| Young Adult | 5 | 2020 | 4012 | 0.300 |
Why?
|
| Male | 11 | 2020 | 18870 | 0.290 |
Why?
|
| Humans | 15 | 2020 | 34853 | 0.270 |
Why?
|
| Qualitative Research | 2 | 2018 | 393 | 0.270 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 248 | 0.240 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 30 | 0.240 |
Why?
|
| Thrombosis | 1 | 2004 | 61 | 0.230 |
Why?
|
| Middle Aged | 5 | 2020 | 9642 | 0.220 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 790 | 0.220 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 2561 | 0.180 |
Why?
|
| Pilot Projects | 2 | 2020 | 628 | 0.180 |
Why?
|
| Sexual Behavior | 2 | 2020 | 587 | 0.180 |
Why?
|
| Gender Identity | 1 | 2020 | 93 | 0.180 |
Why?
|
| Adolescent | 4 | 2017 | 5035 | 0.180 |
Why?
|
| Logistic Models | 3 | 2010 | 894 | 0.160 |
Why?
|
| Cultural Competency | 1 | 2018 | 120 | 0.160 |
Why?
|
| Universities | 1 | 2020 | 363 | 0.150 |
Why?
|
| Interviews as Topic | 2 | 2009 | 356 | 0.150 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 1426 | 0.140 |
Why?
|
| Lead Poisoning | 1 | 2016 | 24 | 0.140 |
Why?
|
| Sex Factors | 2 | 2017 | 859 | 0.140 |
Why?
|
| Human Rights | 1 | 2015 | 7 | 0.140 |
Why?
|
| Community-Based Participatory Research | 1 | 2018 | 292 | 0.130 |
Why?
|
| Lead | 1 | 2016 | 87 | 0.130 |
Why?
|
| Age Factors | 1 | 2017 | 1007 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 1003 | 0.120 |
Why?
|
| Health Surveys | 1 | 2015 | 358 | 0.120 |
Why?
|
| Social Support | 1 | 2015 | 356 | 0.110 |
Why?
|
| United States | 3 | 2010 | 3894 | 0.100 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2010 | 7 | 0.100 |
Why?
|
| AIDS Serodiagnosis | 1 | 2010 | 25 | 0.090 |
Why?
|
| Women's Health | 1 | 2010 | 135 | 0.090 |
Why?
|
| Plasmapheresis | 1 | 2009 | 2 | 0.090 |
Why?
|
| Sex Offenses | 1 | 2009 | 33 | 0.090 |
Why?
|
| Blood Donors | 1 | 2009 | 17 | 0.090 |
Why?
|
| California | 2 | 2008 | 436 | 0.090 |
Why?
|
| Condoms | 1 | 2010 | 132 | 0.090 |
Why?
|
| Abortion, Therapeutic | 1 | 2007 | 1 | 0.080 |
Why?
|
| Luteolytic Agents | 1 | 2007 | 1 | 0.080 |
Why?
|
| Cloprostenol | 1 | 2007 | 3 | 0.080 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2007 | 9 | 0.080 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2007 | 9 | 0.080 |
Why?
|
| Misoprostol | 1 | 2007 | 26 | 0.080 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2008 | 165 | 0.070 |
Why?
|
| Social Class | 1 | 2007 | 228 | 0.070 |
Why?
|
| Risk Factors | 2 | 2010 | 3414 | 0.060 |
Why?
|
| Fibrinopeptide B | 1 | 2004 | 1 | 0.060 |
Why?
|
| Ancrod | 1 | 2004 | 2 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2004 | 14 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2004 | 23 | 0.060 |
Why?
|
| Heparin | 1 | 2004 | 34 | 0.060 |
Why?
|
| Dogs | 1 | 2004 | 138 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2004 | 97 | 0.060 |
Why?
|
| Child | 1 | 2009 | 2875 | 0.050 |
Why?
|
| Cooking and Eating Utensils | 1 | 2016 | 2 | 0.040 |
Why?
|
| Ceramics | 1 | 2016 | 4 | 0.040 |
Why?
|
| Medicine, Traditional | 1 | 2016 | 20 | 0.040 |
Why?
|
| Rural Population | 1 | 2016 | 253 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2016 | 207 | 0.030 |
Why?
|
| History, 16th Century | 1 | 2008 | 4 | 0.020 |
Why?
|
| HIV Antibodies | 1 | 2008 | 29 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2007 | 8 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2007 | 58 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2007 | 16 | 0.020 |
Why?
|
| Urban Health | 1 | 2008 | 86 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2009 | 120 | 0.020 |
Why?
|
| Animals | 1 | 2004 | 14307 | 0.020 |
Why?
|
| Developing Countries | 1 | 2007 | 97 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2007 | 141 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2008 | 429 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2007 | 1349 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1425 | 0.010 |
Why?
|
| Pregnancy | 1 | 2007 | 1503 | 0.010 |
Why?
|